Christopher Twitty
Patrimonio netto: 46 145 $ in data 31/07/2026
Patrimonio netto: 46 145 $ in data 31/07/2026
Christopher G.
Twitty is Chief Scientific Officer at Skye Bioscience, Inc. since 2022.
Formerly, Dr. Twitty was Independent Director at Larkspur Health Acquisition Corp., Chief Scientific Officer, Head-R&D at OncoSec Medical, Inc. from 2017 to 2021, and Chief Scientific Officer at Onchilles Pharma, Inc. from 2021 to 2022.
Education includes a doctorate from Oregon Health & Science University and an undergraduate degree from San Diego State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 81.242 ( 0,23% ) | 46 145 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Direttore Tecnico/Scientifico/R&S | 13/12/2022 |
| Società | Posizione | Fine |
|---|---|---|
Onchilles Pharma, Inc.
Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Direttore Tecnico/Scientifico/R&S | 01/12/2022 |
| ONCOSEC MEDICAL INCORPORATED | Direttore Tecnico/Scientifico/R&S | 20/10/2021 |
| LARR HEALPAR | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oregon Health & Science University
Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Onchilles Pharma, Inc.
Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Commercial Services |
Larkspur Health Acquisition Corp.
Larkspur Health Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale